| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/25/1997 | US5614547 Small molecule inhibitors of rotamase enzyme |
| 03/25/1997 | US5614541 Pharmacologically active catechol derivatives |
| 03/25/1997 | US5614540 Compounds useful for treating allergic and inflammatory diseases |
| 03/25/1997 | US5614537 Enzyme inhibitors of proline hydroxylase for inhibition of collagen biosynthesis and deposition |
| 03/25/1997 | US5614514 Steroid esters |
| 03/25/1997 | US5614491 Liquid preparations containing cyclosporin and process for preparing same |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | CA2080040C Methods for preventing mycobacterial infections by administration of rifabutin |
| 03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
| 03/25/1997 | CA1339007C Collagen wound healing matrices and process for their production |
| 03/20/1997 | WO1997010230A1 Diarylalkenylamine derivatives |
| 03/20/1997 | WO1997010216A1 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals |
| 03/20/1997 | WO1997010005A2 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 03/20/1997 | WO1997003654A3 Pharmaceutical compositions |
| 03/20/1997 | CA2232161A1 Diarylalkenylamine derivatives |
| 03/20/1997 | CA2231687A1 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 03/20/1997 | CA2185850A1 2-cyano-3-mercaptocrotonamides |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763534A1 Arylalkyl-diazinone derivatives as phosphodiesterase IV inhibitors |
| 03/19/1997 | EP0763361A2 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 03/19/1997 | EP0763049A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 03/19/1997 | EP0763048A1 Post exposure prevention of hiv |
| 03/19/1997 | EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763016A1 Compositions and methods for treating mast-cell mediated conditions |
| 03/19/1997 | EP0763013A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents |
| 03/19/1997 | EP0762891A1 Immunogenic pharmaceuticals |
| 03/19/1997 | EP0762888A1 Copolymer-1 improvements in compositions of copolymers |
| 03/19/1997 | EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
| 03/19/1997 | EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis |
| 03/19/1997 | EP0762878A1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection |
| 03/19/1997 | EP0675881B1 Use of benzotriazines as PLA2-Inhibitors and new benzotriazines |
| 03/19/1997 | EP0667770B1 Inhibition of tnf production |
| 03/19/1997 | EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors |
| 03/19/1997 | EP0607373B1 Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 03/19/1997 | EP0566590B1 Particulates |
| 03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 03/19/1997 | CN1145619A Substituted pyridine leukotriene B4 antagonists |
| 03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
| 03/19/1997 | CN1145587A Protease inhibitors |
| 03/19/1997 | CN1145196A Placenta peptide oral liquid and its prodn. method |
| 03/18/1997 | US5612367 Method of enhancing bioavailability of pharmaceutical agents |
| 03/18/1997 | US5612365 Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612356 Retinoid antagonists |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612333 4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl(1h)pyrimidin-2 -one and 11-cyclopropyl-5,11-dihydro-4-methyl-6hdipyrido(3,3b (1,4)diazipine-6-one |
| 03/18/1997 | US5612330 Herpes virus |
| 03/18/1997 | US5612325 Antiinflammatory and immunomodulating effects |
| 03/18/1997 | US5612316 Treatment of resistance to transplantation, fungal infections, and autoimmune diseases |
| 03/18/1997 | US5612217 Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of HIV protease inhibitors |
| 03/18/1997 | US5612209 Allergies |
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/18/1997 | US5612030 Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
| 03/13/1997 | WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | WO1997009325A1 Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| 03/13/1997 | WO1997009298A1 Production of an immunosuppressant using microorganisms |
| 03/13/1997 | WO1997009064A1 Use of muteins of wild-type cytokines as immunogens |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
| 03/13/1997 | WO1997009046A1 Compounds and methods |
| 03/13/1997 | WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract |
| 03/13/1997 | WO1997008934A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide |
| 03/13/1997 | CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2231182A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | CA2230896A1 Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| 03/13/1997 | CA2224874A1 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
| 03/12/1997 | EP0761683A1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 03/12/1997 | EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof |
| 03/12/1997 | EP0761232A1 Antiallergic agent comprising anti-PAF receptor antibodies |
| 03/12/1997 | EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them |
| 03/12/1997 | EP0760860A1 Methods of in vivo gene delivery |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 03/12/1997 | EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/12/1997 | EP0760666A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0648207B1 Vitamin d analogues |
| 03/12/1997 | EP0565587B1 THE EFFECT OF N,N,N-TRIMETHYLSPHINGOSINE ON PROTEIN KINASE-C ACTIVITY; MELANOMA CELL GROWTH $i(IN VITRO); METASTATIC POTENTIAL $i(IN VIVO) AND HUMAN PLATELET AGGREGATION |
| 03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies |
| 03/12/1997 | CN1145033A Human therapeutic uses of BPI protein products |
| 03/12/1997 | CN1145029A Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them |
| 03/12/1997 | CN1034217C Anti-proliferative and anti-inflammatory compounds:derivatives of pentose monosaccharides |
| 03/11/1997 | US5610279 Human TNF receptor |
| 03/11/1997 | US5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy |
| 03/11/1997 | US5610176 Tachykinin (NK1) receptor antagonists |
| 03/11/1997 | US5609871 Microencapsulating enteric coating |
| 03/11/1997 | EP0699442A4 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/07/1997 | CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom |